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Progressive multifocal fibrosing neuropathy:
description of a novel disease
Fabian A. Mendoza1,2* , Jennifer Bagley3, Michael Gochfeld3, Marinos C. Dalakas4,5, John L. Farber6 and
Sergio A. Jimenez2*

Abstract
Entrapment peripheral neuropathies are clinically characterized by sensory impairment and motor deficits. They are
usually caused by mechanical injuries, but they are also a frequent manifestation of metabolic diseases, toxic agent
exposure, or systemic fibrotic disorders. Here we describe the clinical, radiological, and histopathological features
of a novel progressive fibrotic disorder characterized by progressive multifocal fibrosing neuropathy. We identified
two patients who presented with severe and progressive peripheral neuropathic symptoms sequentially affecting
multiple sites. These patients presented with severe and progressive multifocal, sequentially additive peripheral neuropathic symptoms. Extensive nerve conduction and radiological studies showed the sequential development of multifocal motor and sensory peripheral neuropathy in the absence of any exposure to known infectious, inflammatory,
or fibrotic triggers and the lack of family history of compression neuropathies. Extensive clinical and laboratory test
evaluation failed to support the diagnosis of any primary inflammatory or genetic peripheral neuropathy and there
was no evidence of any systemic fibrosing disorder including Systemic Sclerosis, lacking cutaneous fibrotic changes
and cardiopulmonary abnormalities. The clinical course was progressive with sequential development of motor and
sensory deficits of upper and lower extremities displaying proximal predominance. Histopathological study of tissues obtained during nerve release surgeries showed severe perineural fibrosis with marked accumulation of thick
collagen bundles encroaching the peripheral nerves. There was no evidence of vasculitic, inflammatory, or vascular
fibroproliferative lesions. We suggest that the clinical findings described here represent a previously undescribed
fibrotic disorder affecting peripheral nerves, and we propose the descriptive term "Progressive Multifocal Fibrosing
Neuropathy" to refer to this novel disorder. Despite the inherent limitations of this early description, we hope this is
would contribute to the identification of additional cases.
Introduction
Peripheral neuropathies caused by nerve compression
or entrapment syndromes manifest clinically by sensory
impairment and motor deficits. They most commonly
result from chronic mechanical injuries of nerve tracts
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in fibro-osseous canals or compression by other tissue
structures, including tendons, ligaments, and muscles [1,
2]. Slow development of peripheral neuropathies is also
a frequent manifestation of diabetes mellitus (DM) or
toxic agent exposure [3–6]. On the other hand, peripheral neuropathies are an early clinical feature of systemic
sclerosis (SSc) [7] and various related systemic disorders characterized by prominent tissue fibrosis, vascular
alterations and immune-inflammatory changes including
the toxic oil syndrome (TOS), eosinophilia-myalgia syndrome (EMS), nephrogenic systemic fibrosis (NSF), and
eosinophilic fasciitis (EF) [8–14]. Peripheral neuropathies
were particularly frequent and severe in patients with
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TOS who developed perineuritis followed by fibrosis of
the perineurium and fibrosing entrapment neuropathies
[9, 10]. Similarly, in advanced rapidly progressive diffuse
SSc, fibrosing entrapment neuropathies are frequently
present [7, 8].
Here, we describe two patients who developed a novel
disorder characterized by severe and progressive peripheral neuropathy with multifocal and sequential involvement of multiple sites. Extensive neurological and
histopathological studies demonstrated that this process
was caused by encroachment of nerve tracts by the accumulation of large amounts of excessive fibrotic tissue in
the absence of genetic or acquired neurological disorders
or systemic inflammatory or fibrotic diseases. Therefore,
it is suggested that this clinical entity represents a previously undescribed fibrotic disorder affecting the peripheral nerves.

and required pudendal nerve release surgery for relief of
refractory and progressive pain, achieving resolution of
pain. One month later, the patient noticed left foot drop,
associated with severe left buttock pain in the absence of
lumbar pain and lack of trauma. Pain was aggravated on
sitting, and reproduced at palpation. A positive straight
leg sign was found at exam. She was diagnosed with left
piriformis syndrome requiring decompression surgery. A
few months later, the patient developed left common peroneal nerve compression that was treated with repeated
ultrasound-guided corticosteroid injections only with
partial improvement of her symptoms. One year later, a
diagnosis of progressive and severe right thoracic outlet syndrome was made requiring right brachial plexus
release surgery. The extensive fibrotic tissue encroachment of the brachial plexus nerve observed during the
surgical procedure is shown in Fig. 3. Two months later,
the patient presented with right cubital tunnel syndrome
that was treated with ultrasound-guided corticosteroid
injection with initial improvement. However, owing to
recurrent and worsening symptoms, she required ulnar
nerve release surgery. Most recently, she developed right
piriformis compression syndrome, and release surgery is
being considered. The sequential peripheral neurological involvement is illustrated in Fig. 1a. During all surgical release procedures, large amounts of fibrotic tissue
encasing and compressing the affected nerves were found
and removed. The histopathological studies of the tissues
removed at surgery are shown in Fig. 2a. Electrophysiological studies performed at various times of her disease,
corroborated the presence of entrapment neuropathies,
and correlated with imaging and surgical findings.

Methods
Both patients were referred to the Scleroderma Center at
Thomas Jefferson University for evaluation of a systemic
fibrosing disorder causing progressive neuropathy affecting multiple peripheral nerves. Appropriate laboratory
tests for the assessment of SSc and SSc-like disorders,
including autoantibody testing, nail-fold video-capillaroscopy, pulmonary function tests, high-resolution chest
computed tomography, and echocardiograms were performed. Neurological evaluations, including extensive
clinical and electrophysiological assessment, were performed by a neuromuscular neurologist (M.C.D); and
radiological studies included resonance imaging (MRI),
and ultrasonography. Histopathological studies of biopsies from affected nerves and surrounding tissue obtained
during decompression surgeries were performed. The tissues were stained with hematoxylin–eosin (H&E), and
Masson’s Trichrome stains, immunohistochemistry studies for inflammatory cell markers including CD3, CD8,
CD20, and CD68 were performed. A search for peripheral myelin protein (PMP22) gene mutations to exclude
hereditary neuropathy with liability to pressure palsies
(HNPP) was performed in both patients (Athena Diagnostics, MA).
Results
Clinical features and auxiliary tests
Patient 1

A 37-year-old female presented with three months history of severe pain localized to the left genital area. An
initial evaluation was negative for infectious etiologies.
Owing to the persistence of symptoms, an MRI was
performed. The study disclosed soft-tissue edema surrounding the left pudendal nerve (Fig. 1a, upper insert).
She was diagnosed with left pudendal nerve neuropathy

Patient 2

A 25-year-old female patient with unremarkable medical history presented with vulvar and vaginal burning,
numbness, and electric-type pain that first started three
years prior to her initial visit. A comprehensive gynecological evaluation was unremarkable including negative investigation for sexually transmitted diseases. A
pelvic MRI was performed shortly after the onset of her
symptoms showing no structural abnormalities. She was
treated with Gabapentin with partial improvement. However, few months later, her initial symptoms evolved to
progressive numbness and constant neuropathic pain in
the right hemi-pelvic area. A new MRI showed soft tissue
“edema” and an ill-defined and enlarged right pudendal
nerve (Fig. 1b lower insert). The patient failed to improve
with physiotherapy and analgesics and underwent diagnostic (lidocaine) nerve blocking of the Ilioinguinal, iliohypogastric and genital branches of the genitofemoral
nerve with full but transient resolution of her symptoms.
Consequently, a neurectomy was performed two years

Mendoza et al. Acta Neuropathologica Communications

Paent 1

1 month

(2022) 10:34

Page 3 of 7

6 months

12 month

1 month

*

L sciac nerve (piriformis)

L pudendal nerve

L common peroneal nerve

R thoracic outlet
Syndrome

R cubital nerve
R sciac nerve

Paent 2

3 months

R pudendal nerve

*
*

2 months

R cubital nerve

12 month

R brachial plexus

R cubital nerve

*MRI of the pelvis (T2), showing focal enhancement at the level of the pudendal nerve
Fig. 1 Time course and sequential development of peripheral nerve involvement. The new areas of involvement at each timepoint (red circles)
are shown with the blue arrows. The inserts show MRIs (T2) of both patients displaying pudendal nerve compression by a large mass-type lesion
(arrows) located near to the left ischial tuberosity in patient 1 and right iliac tuberosity and iliac bone in patient 2

Fig. 2 Histopathologic study of the affected tissue. Light microscopy of tissue from the left posterior femoro-cutaneous/pudendal nerve area and
the right brachial area from patients 1 and 2 respectively (A and B). H&E staining (A-B) and Mason Trichrome staining (C-D) show severe fibrosis
without inflammatory infiltrates encasing small nerves. Axonal swelling is also evident. There is absence of fibroproliferative, inflammatory, or
vasculitic small vessel involvement. Various magnifications were used
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Fig. 3 Macroscopic aspect of affected nerves. Macroscopic appearance of the right brachial plexus nerves during the surgical procedure is shown.
Adhesions and perineural fibrosis surrounding and encasing nerves are displayed at the left, compared with post-surgical removal of fibrotic tissue
at the right

following the onset of symptoms with complete resolution of pain. Three months after the procedure she developed numbness, burning, pain, and weakness of the area
innervated by the right cubital nerve. She underwent
electrophysiological studies (NC/EMG) that corroborated a mild right ulnar mononeuropathy. She was treated
with physical/occupational therapy with stabilization
of her symptoms. Two months later, the patient noted
severe, spontaneous right shoulder pain radiating to the
right arm. Imaging studies including ultrasound and
MRI disclosed alterations consistent with right brachial
plexus inflammation as well as mild edema at the right
cubital tunnel. NC/EMG showed patchy involvement in
brachial plexus distribution and bilateral ulnar entrapment neuropathy. There was no evidence of peripheral
polyneuropathy, cervical radiculopathy, or myopathy on
this study. The sequential peripheral nerve involvement is
shown in Fig. 1b. Owing to rapidly progressive and worsening symptoms that included whole arm weakness, right
brachial decompression surgery was performed three
months later. A sample of tissue was obtained during
this procedure. The histopathologic exam showed extensive perineural fibrosis encasing and compressing the
visualized nerves that showed axonal swelling as shown
in Fig. 2b. One year after this procedure, she developed
worsening right hand and forearm motor and sensory
symptoms and was treated with an ultrasound-guided
nerve hydro-dissection with partial improvement.
The extensive clinical evaluation in both patients
did not disclose skin thickening, digital ulcers, cardiopulmonary symptoms, mouth opening restriction,

telangiectasias, or calcinosis. However, in patient 1, there
was a history of mild Raynaud’s phenomenon symptoms
without painful episodes or digital ulcers. Detailed questioning in both patients, failed to disclose any exposure
to gadolinium-based contrast agents (GdBCA), silica,
organic solvents, pesticides, radiation, occupation/hobby
exposures, or other identifiable environmental factors.
No family history of a similar syndrome was found. Laboratory testing in both cases showed the absence of eosinophilia and tests for antinuclear antibody were negative.
Repeated analysis failed to show elevation of inflammatory markers (ESR and CRP). Genetic testing did not
disclose any peripheral myelin protein 22 (PMP22) mutations. An echocardiogram did not show signs of pulmonary hypertension or myocarditis, and pulmonary
function tests (PFTs) were normal. There was no clinical
or laboratory evidence to suggest the diagnosis of diabetes mellitus.
Given the fact that the findings of EMG/NC studies
correlated with the clinical picture in both patients and
provided imaging evidence of entrapment neuropathy,
lumbar puncture and CSF analysis were not performed.
Magnetic resonance and ultrasound studies

MRI of the pelvic area showed marked perineural edema
surrounding the left pudendal nerve of patient 1 and
right pudendal nerve in patient 2 (Fig. 1, inserts), and
subsequent imaging studies of both patients including
ultrasound studies of multiple nerves showed echo-density abnormalities compatible with perineural edema and
fibrotic tissue encroaching multiple nerves (not shown).
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Histopathology studies

Samples of perineural tissue were obtained during the
left pudendal nerve release surgery in patient 1 and during the brachial plexus surgery in patient 2. Representative images of the histopathologic results are shown in
Fig. 2. H&E and Mason’s trichrome staining showed
large amounts of fibrotic tissue with thick collagen bundles surrounding and encasing small nerve tracts in both
patients. Axonal swelling is present. No evidence of perineural inflammatory cell infiltration was evident on the
samples examined by H&E and immunohistochemistry.
Extensive examination of tissue vessels failed to show any
evidence of proliferative vasculopathy, vessel narrowing,
or a vasculitic process.

Discussion
There are several systemic fibrotic disorders commonly
associated with peripheral neuropathy, including SSc,
TOS, EF, EMS, and NSF [7–15]. However, without exception, these diseases display prominent diffuse skin and
internal organ fibrotic involvement. Furthermore, these
disorders display a prominent inflammatory component
in affected tissues as illustrated by the inflammatory cellinduced activation of quiescent fibroblasts described in
EMS [14]. In other metabolic conditions, such as DM,
the progression of the entrapment neuropathies caused
by remodeling of the extracellular matrix, is slow without an inflammatory reaction [16]. Although there was
no clinical evidence of SSc or other scleroderma-like
systemic fibrosing disease, the first patient presented
Raynaud’s phenomenon suggesting that vasospastic vasculopathy may be a feature of the disease. However, there
was no evidence of microvascular alterations at nailfold
videocapillaroscopy.
Another clinical condition mimicking some of the
symptoms of the patients presented here is hereditary
neuropathy with liability to pressure palsies (HNPP)
[17, 18], an autosomal dominant inherited disorder usually caused by under-production of PMP-22 due to a
partial deletion on chromosome 17 [17–19]. However,
fibrotic lesions have not been described in this condition. Importantly the clinical phenotype of both patients
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was inconsistent with HNNP as their neuropathy was
progressive due to a steady and continuous built-up of
fibrotic tissues surrounding multiple peripheral nerves.
Furthermore, the clinical manifestations were unrelated to compression events and without spontaneous
improvement. Furthermore, both patients were tested for
HNPP related mutations (PMP22) and the gene sequencing studies failed to show any abnormalities. In both
cases there was clear evidence of both sensory and motor
neurologic involvement, thereby excluding multifocal
motor neuropathy that presents only with motor involvement [20].
Given the fact that several systemic fibro-inflammatory
conditions have been related to an exogenous triggering
agent, an extensive and detailed inquiry was performed
but failed to disclose any toxic exposure. Although
patients with more than one neuropathic compressive
syndrome affecting the same extremity, usually associated with thoracic outlet syndrome have been described
and a “double crush mechanism” was proposed for those
cases [21, 22], in the patients presented here, the asymmetric distribution of the multiple involvement of deep
peripheral nerves including pelvic, pudendal and thoracic
nerves cannot be attributed to thoracic outlet syndrome
or a “double crush mechanism”.
An extensive review of the published medical literature
indicates that there was no previously described syndrome or disease with the clinical and histopathological
findings described in this report and the cases and the
cases studied and reported appear to be unique. Therefore, it is suggested that this may represent a novel clinical entity descriptively termed "Multifocal Progressive
Fibrosing Neuropathy". The most important features distinguishing Multifocal Progressive Fibrosing Neuropathy
from SSc, TOS, EF, EMS, and NSF, and other neurological diseases frequently causing neuropathy are listed in
Tables 1, 2. It is anticipated that the early description of
this novel disorder may allow the identification of additional patients and thereby provide further information
regarding its possible etiology.
Finally, we can hypothesize that owing the absence
of inflammation in immunopathological studies but

Table 1 Differences in the clinical features of selected systemic fibrotic diseases with Progressive Multifocal Fibrosing Neuropathy
Nerve entrapment Raynaud’s
Sclerodactyly Skin fibrosis
phenomenon

Lung/heart involvement ANA/specific
Autoantibodies

Progressive Multifocal Fibrosing Present
Neuropathy

Present

Absent

Absent

Absent

Absent

Systemic Sclerosis

Present, frequently

Present

Present

Present

Present

Present,

Eosinophilia Myalgia Syndrome Present

Absent

Present

Present, diffuse Present

Absent

Nephrogenic Systemic Fibrosis

Present

Absent

Absent

Present, varies

Present

Absent

Toxic Oil Syndrome

Present

Rare

Present

Present

Present

Absent
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Table 2 Differences in the clinical features of selected neurological diseases with Progressive Multifocal Fibrosing Neuropathy
Multiple
Nerve
involvement

Hereditary Component Clinical features

History of trauma

Histopathology

Progressive Multifocal
Fibrosing Neuropathy

Present

None

Sensory and motor loss

Absent

Marked Fibrosis in
epineurium, perineurium. &
endoneurium

HNPP (Hereditary neuropathy with liability to
pressure palsies)

Present

Autosomal Dominant

Sensory and motor loss

Present

Multifocal thickening of
peripheral myelin

Multifocal Motor neuropathy

Present

None

Motor loss only.
Predominantly upper
extremities

Absent

Multifocal fiber degeneration, altered size distribution, regenerating fibers

Diabetic Neuropathy

Present

Varies

Sensory and motor loss

Present (Microtrauma) Mild fibrosis

significant fibrosis, these patients could benefit from the
use of antifibrotic drugs.
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